Abstract:Context: The incidence of urinary tract stone disease is increasing and the risk of recurrent stone formation is high. Appropriate therapeutic procedures with the aim of counteracting the progress of stone formation are highly desirable. Metabolic work-up is considered essential as a base for optimal design and follow-up of effective recurrence prevention. Objective: To scrutinize the current literature with regard to principles of metabolic work-up for this heterogeneous group of patients. Evidence acquisition: Relevant articles in PubMed, guideline documents, consensus reports, and the Cochrane Library published during the past 20 yr were consulted. Evidence synthesis: Grades of recommendation were used according to the principles applied in the European Association of Urology and American Urological Association guidelines. Medical efforts to prevent recurrent stone formation should be part of the care of patients with urinary tract stone disease (grade of recommendation A). A careful medical history and imaging together with analysis of stone composition, blood, and urine provide the basis for appropriate measures, but the treatment has to be individualized (grade of recommendation D). Whenever possible, stone analysis should be carried out at least once for every patient or each time when a long time has elapsed between two stone episodes because the risk factors explaining stone formation may have changed (clinical principle). The medical history, including information on dietary and drinking habits as well as lifestyle, is necessary for appropriate advice (grade of recommendation C). The medical history, together with imaging and stone composition, is used to estimate the severity of the disease (clinical principle). Identification of specific medical conditions should be supported by blood and/or urine analysis (grade of recommendation B). Pharmacological agents associated with an increased risk of stone formation should be identified (grade of recommendation C). Patients who have formed noncalcium stones should always be given recurrence preventive treatment. Analysis of urine composition for these patients is optional, but might be of value in the follow-up to support decisions on appropriate dosage regimens (grade of recommendation C). For patients with idiopathic calcium stone disease information from 24-h urine samples should be used, although the number of samples to be taken is debated (grade of recommendation C). Information from 24-h urine analysis should be used for selective dietary and drinking advice as well as for selection of the most appropriate pharmacological agent (grade of recommendation B). The treatment effects on the risk of stone formation can be followed by estimates of supersaturation based on urine composition (grade of recommendation C). Conclusions: It is clear that the metabolic work-up of patients with urinary tract stone disease should be individualized according to stone type and severity of the disease, and that the different therapeutic approaches are closely associated with the availability of therapeutic tools and motivation by the patient. Patient summary: Effective prevention of recurrent stone formation is determined by several factors such as the current and previous stone episodes and surgical procedures, stone composition, medical history, dietary and drinking habits, lifestyle, and ongoing pharmacological therapy. Analysis of blood and urine is an important part of the metabolic evaluation, but how extensive the risk evaluation should be is determined by the type of stone and the severity of the disease.

The organic-inorganic hybrid material 1-cyclohexylpiperazine-1,4-diium tetrachloridozincate.

[Usefulness of beta-2-microglobulin determination in the differential diagnosis of infections in the upper and lower parts of the urinary tract]

�2-Microglobulin and Other Proteins as Parameter for Tubular Function1

A Theory of Classes for a Functional Language with Effects

[Evaluation of selected indicators of the renal proximal tubule function in patients treated with gentamicin]

Metabolic syndrome and the urinary microbiome of patients undergoing percutaneous nephrolithotomy

Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm

Reduced Axonopathy and Enhanced Remyelination After Chronic Demyelination in Fibroblast Growth Factor 2 (Fgf2)-Null Mice: Differential Detection With Diffusion Tensor Imaging

Adenylosuccinate synthetase from Azotobacter vinelandii: purification, properties and steady-state kinetics.

DELAYED CARDIAC ALLOGRAFT REJECTION DUE TO COMBINED CYCLOSPORINE AND ANTIOXIDANT THERAPY

Fibular fixation as an adjuvant to tibial intramedullary nailing in the treatment of combined distal third tibia and fibula fractures: a biomechanical investigation.

Preservation of urine specimens for metabolic evaluation of recurrent urinary stone formers

Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy

Trends in renal calculus composition and 24-hour urine analyses in patients with neurologically derived musculoskeletal deficiencies

Surface design of carbon nanotubes for optimizing the adsorption and electrochemical response of analytes.

Metabolic Differences Between Unilateral and Bilateral Renal Stones and Their Association with Markers of Kidney Injury

[Study of genetic diversity and spatial structure of the wild soybean (Glycine soja Sieb. & Zucc.) population from the Ekaterinovka in the south of Primorskii krai].

Urinary Angiotensinogen is Elevated in Patients with Nephrolithiasis

Evaluation of Urinary Biomarkers of Proximal Tubular Injury, Inflammation, and Fibrosis in Patients With Albuminuric and Nonalbuminuric Diabetic Kidney Disease

Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients

Assessment of Plasma Cystatin C as a Marker of Acute Renal Injury in Patients Undergoing Extracorporeal Shock Wave Lithotripsy for Renal Stone Disease